Type 1 diabetes is diagnosed through blood tests that measure blood sugar levels, followed by additional tests that confirm the immune system is attacking the pancreas. A fasting blood glucose of 126 mg/dL or higher, or a random blood glucose of 200 mg/dL or higher with symptoms like extreme thirst and frequent urination, triggers the diagnostic process. But confirming that it’s specifically type 1, rather than type 2 or another form, requires a deeper look at autoimmune markers and insulin production.
Blood Sugar Tests That Start the Process
The same initial blood tests are used to diagnose all forms of diabetes. Any one of these results, confirmed on a second occasion, meets the threshold for a diabetes diagnosis:
- Fasting blood glucose: 126 mg/dL or higher after no food for at least 8 hours
- A1C: 6.5% or higher, reflecting average blood sugar over the past 2 to 3 months
- Oral glucose tolerance test: 200 mg/dL or higher two hours after drinking a standardized glucose solution
- Random blood glucose: 200 mg/dL or higher at any time, combined with classic symptoms
In many type 1 cases, especially in children, blood sugar is already dramatically high by the time someone sees a doctor. The random glucose test paired with obvious symptoms is often enough to begin treatment immediately, with confirmatory testing happening afterward. When type 1 develops more gradually, particularly in adults, the fasting glucose or A1C test may catch it earlier.
One important caveat: the A1C test can give misleading results in people with certain blood conditions. Sickle cell trait and other hemoglobin variants, chronic anemia, significant blood loss, pregnancy, and kidney disease can all skew A1C readings in either direction. If any of these apply, direct blood glucose measurements are more reliable for diagnosis.
Autoantibody Tests That Confirm Type 1
High blood sugar tells you someone has diabetes. Autoantibody tests tell you it’s type 1. These blood tests detect immune proteins that mistakenly target the insulin-producing cells of the pancreas. Four autoantibodies are routinely tested:
- GAD antibodies (GADA): target an enzyme in the pancreas and are the most commonly tested marker in adults
- Insulin autoantibodies (IAA): target insulin itself, most useful in young children before insulin treatment begins
- IA-2 antibodies: target a protein on the surface of insulin-producing cells
- ZnT8 antibodies: target a zinc transporter involved in insulin storage
Testing positive for at least two of these autoantibodies on two separate blood draws is the standard for confirming autoimmune diabetes. A single positive result can support the diagnosis, but two or more provide much stronger certainty. Not every lab tests for all four markers, but most will at least check GAD antibodies and one or two others.
About 5 to 10% of people with type 1 diabetes test negative for all known autoantibodies. In these cases, doctors rely on the overall clinical picture: the speed of onset, age, body type, and how the body responds to treatment.
C-Peptide: Measuring Insulin Production
C-peptide is a molecule released by the pancreas in equal amounts to insulin. Measuring it gives a reliable picture of how much insulin your body is actually making. In type 1 diabetes, C-peptide levels are low because the immune system has destroyed the cells responsible for insulin production. In type 2 diabetes, C-peptide is typically normal or even high, because the problem is insulin resistance rather than a lack of insulin.
This test is especially useful in ambiguous cases. If someone is diagnosed with diabetes in their 20s or 30s and their doctor isn’t sure whether it’s type 1 or type 2, a low C-peptide result combined with positive autoantibodies points strongly toward type 1. The test can be done fasting or after a meal, since eating stimulates insulin release and makes the difference between low and normal production easier to spot.
The Three Stages of Type 1 Diabetes
Type 1 diabetes doesn’t appear overnight, even though it can feel that way. The disease progresses through three recognized stages, and understanding them explains why some people are diagnosed before symptoms ever appear.
In stage 1, two or more autoantibodies are present in the blood, meaning the immune attack on the pancreas has begun. But blood sugar levels are still completely normal, and there are no symptoms. People at this stage are typically identified only through screening programs, often because a close relative has type 1.
In stage 2, the ongoing destruction of insulin-producing cells starts to show up as abnormal blood sugar. Fasting glucose or glucose tolerance test results drift into the prediabetic or early diabetic range. There are still no noticeable symptoms. The progression from stage 2 to stage 3 varies widely, from months to years.
Stage 3 is what most people think of as “getting diagnosed.” Enough insulin-producing cells have been destroyed that the body can no longer regulate blood sugar. This is when the classic symptoms appear: frequent urination, intense thirst, unexplained weight loss, fatigue, and blurry vision. Most people are diagnosed at this stage because the symptoms become impossible to ignore.
When Diagnosis Happens in an Emergency
About 30 to 40% of children with new-onset type 1 diabetes are first diagnosed during a medical emergency called diabetic ketoacidosis, or DKA. This happens when the body has so little insulin that it starts breaking down fat for energy at a dangerous rate, producing acids called ketones that build up in the blood.
DKA is diagnosed when blood glucose is above 250 mg/dL, blood ketones are elevated, blood pH drops below 7.3 (normal is around 7.4), and bicarbonate levels fall below 18 mEq/L. Symptoms include nausea, vomiting, abdominal pain, rapid breathing, and a fruity smell on the breath. Severe cases can involve confusion or loss of consciousness.
If someone arrives at the emergency room in DKA and has never been diagnosed with diabetes, the combination of very high blood sugar, ketones, and their age and body type often points immediately to type 1. Autoantibody and C-peptide tests are typically run afterward to confirm.
Conditions That Mimic Type 1
Not every case of diabetes in a young, lean person is type 1. Two conditions in particular can look similar and require different testing to sort out.
Latent autoimmune diabetes in adults, sometimes called LADA or type 1.5, is a slow-moving form of autoimmune diabetes that appears in people over 30. It’s often initially mistaken for type 2 because the onset is gradual and blood sugar can be managed with oral medications for months or even years. The clue that it’s actually autoimmune comes when those medications stop working. A GAD antibody test and C-peptide test will reveal the true diagnosis: positive autoantibodies and declining insulin production.
Maturity-onset diabetes of the young (MODY) is a genetic form of diabetes caused by a single gene mutation, not an autoimmune attack. Doctors typically suspect MODY when someone is diagnosed before age 30, has a strong family history of diabetes across multiple generations, doesn’t have overweight or obesity, and tests negative for autoantibodies. Genetic testing is the only way to confirm it, and the distinction matters because some forms of MODY respond well to specific treatments that differ from standard type 1 management.
What the Diagnostic Process Looks Like
For most people, the experience follows a predictable path. You or your child develops symptoms, a blood sugar test comes back high, and the diagnosis of diabetes is made quickly, sometimes that same day. From there, autoantibody testing and possibly a C-peptide test are ordered to confirm it’s type 1. Those results may take a few days to a couple of weeks to come back, depending on the lab.
In the meantime, if blood sugar is very high or ketones are present, insulin treatment starts immediately. You don’t need to wait for autoantibody results before beginning treatment. The confirmatory tests matter for long-term management planning, but they don’t change the urgency of getting blood sugar under control.
For adults, the process can be less straightforward. If you’re in your late 20s or older and don’t fit the typical profile for type 2, you may need to advocate for autoantibody testing. Some providers default to a type 2 diagnosis based on age alone, and it can take months of treatment failure before the correct diagnosis is pursued. If oral diabetes medications aren’t controlling your blood sugar and you’re losing weight without trying, asking specifically about autoantibody and C-peptide testing can speed up getting the right answer.